Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 150

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 11
Chunk 150
---
Item 11.
Quantitative and Qualitative Disclosures about Market Risk

Our cash consists entirely
of cash held in interest-bearing accounts with banks in Australia and overseas. Thus, our primary exposure to market risk are foreign
exchange rate fluctuations and interest income sensitivity, which is affected by changes in the general level of interest rates. However,
a sudden change in market interest rates would not be expected to have a material impact on our financial condition or results of operation.
In addition, we are exposed to credit risk due to increased cash and cash equivalents. See note 10 in the notes to our financial statements
for more information.

Item 12.
Description of Securities Other Than Equity Securities